Skip to main navigation Skip to search Skip to main content

Redox imbalance in COVID-19 pathophysiology

  • Nairrita Majumder
  • , Vishal Deepak
  • , Sarah Hadique
  • , Drake Aesoph
  • , Murugesan Velayutham
  • , Qing Ye
  • , Md Habibul Hasan Mazumder
  • , Sara E. Lewis
  • , Vamsi Kodali
  • , Anthony Roohollahi
  • , Nancy Lan Guo
  • , Gangqing Hu
  • , Valery V. Khramtsov
  • , Richard J. Johnson
  • , Sijin Wen
  • , Eric E. Kelley
  • , Salik Hussain
  • West Virginia University
  • University of Colorado Anschutz Medical Campus

Research output: Contribution to journalArticlepeer-review

18 Scopus citations

Abstract

Background: The pathophysiologic significance of redox imbalance is unquestionable as numerous reports and topic reviews indicate alterations in redox parameters during corona virus disease 2019 (COVID-19). However, a more comprehensive understanding of redox-related parameters in the context of COVID-19-mediated inflammation and pathophysiology is required. Methods: COVID-19 subjects (n = 64) and control subjects (n = 19) were enrolled, and blood was drawn within 72 h of diagnosis. Serum multiplex assays and peripheral blood mRNA sequencing was performed. Oxidant/free radical (electron paramagnetic resonance (EPR) spectroscopy, nitrite-nitrate assay) and antioxidant (ferrous reducing ability of serum assay and high-performance liquid chromatography) were performed. Multivariate analyses were performed to evaluate potential of indicated parameters to predict clinical outcome. Results: Significantly greater levels of multiple inflammatory and vascular markers were quantified in the subjects admitted to the ICU compared to non-ICU subjects. Gene set enrichment analyses indicated significant enhancement of oxidant related pathways and biochemical assays confirmed a significant increase in free radical production and uric acid reduction in COVID-19 subjects. Multivariate analyses confirmed a positive association between serum levels of VCAM-1, ICAM-1 and a negative association between the abundance of one electron oxidants (detected by ascorbate radical formation) and mortality in COVID subjects while IL-17c and TSLP levels predicted need for intensive care in COVID-19 subjects. Conclusion: Herein we demonstrate a significant redox imbalance during COVID-19 infection affirming the potential for manipulation of oxidative stress pathways as a new therapeutic strategy COVID-19. However, further work is requisite for detailed identification of oxidants (O2•-, H2O2 and/or circulating transition metals such as Fe or Cu) contributing to this imbalance to avoid the repetition of failures using non-specific antioxidant supplementation.

Original languageEnglish
Article number102465
JournalRedox Biology
Volume56
DOIs
StatePublished - Oct 2022

Keywords

  • COVID-19
  • EPR
  • Electron paramagnetic resonance
  • Redox imbalance
  • SARS-CoV-2
  • Transcriptomics
  • Uric acid

Fingerprint

Dive into the research topics of 'Redox imbalance in COVID-19 pathophysiology'. Together they form a unique fingerprint.

Cite this